Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older
If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax COVID-19 Vaccine, Adjuvanted...